DarioHealth Corp. (DRIO)

DarioHealth Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.63	21.8	27.76	36.8	49.36	35.81
Short-Term Investments	7.33	4.21	0.7	-	-	-
Cash & Short-Term Investments	13.96	26.02	28.46	36.8	49.36	35.81
Cash Growth	-36.41%	-8.59%	-22.65%	-25.45%	37.84%	25.25%
Accounts Receivable	1.55	2.14	4.8	3.16	6.42	1.31
Other Receivables	2.31	0.53	0.29	0.25	0.24	0.08
Receivables	3.86	2.67	5.09	3.41	6.66	1.79
Inventory	3.72	4.32	4.75	5.06	7.96	6.23
Prepaid Expenses	-	1.58	1.79	1.54	0.91	1.59
Other Current Assets	0.59	0.49	0.43	0.53	0.65	0.19
Total Current Assets	22.13	35.07	40.53	47.33	65.52	45.61
Property, Plant & Equipment	1.53	1.27	1.77	1.87	1.99	0.99
Goodwill	57.43	57.43	57.43	41.64	41.64	41.64
Other Intangible Assets	15	15.93	18.76	5.4	9.92	12.46
Long-Term Deferred Charges	0.32	0.18	0.07	0.06	0.04	-
Other Long-Term Assets	0.18	0.21	0.33	0.09	0.08	0.08
Total Assets	96.59	110.08	118.88	96.39	119.19	100.77

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.17	2.93	3.05	1.13	2.32	5.11
Accrued Expenses	5.31	5.25	6.05	6.3	6.59	7.81
Current Portion of Long-Term Debt	-	-	5.45	3.95	8.82	-
Current Portion of Leases	0.57	0.43	0.5	0.11	0.29	0.27
Current Unearned Revenue	0.52	0.71	1.58	1	1.32	1.2
Total Current Liabilities	9.58	9.32	16.64	12.49	19.35	14.38
Long-Term Debt	31.06	30.75	23.47	24.59	18.11	-
Long-Term Leases	0.78	0.57	0.77	0.89	0.83	0.02
Other Long-Term Liabilities	0.08	1.51	5.99	0.28	0.91	0.83
Total Liabilities	41.5	42.15	46.87	38.25	39.19	15.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	523.34	520	462.36	407.5	365.85	307.56
Retained Earnings	-468.25	-452.08	-390.34	-349.36	-285.85	-222.01
Total Common Equity	55.09	67.92	72.02	58.14	80	85.55
Shareholders' Equity	55.09	67.92	72.02	58.14	80	85.55
Total Liabilities & Equity	96.59	110.08	118.88	96.39	119.19	100.77

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	32.41	31.75	30.19	29.54	28.05	0.29
Net Cash (Debt)	-18.45	-5.73	-1.73	7.26	21.31	35.52
Net Cash Growth	-	-	-	-65.95%	-40.01%	26.60%
Net Cash Per Share	-2.50	-1.44	-0.71	5.11	18.03	42.82
Filing Date Shares Outstanding	9.8	7.3	2.08	1.47	1.29	1.09
Total Common Shares Outstanding	7.34	6.91	1.92	1.36	1.29	0.83
Working Capital	12.55	25.74	23.89	34.84	46.17	31.23
Book Value Per Share	7.50	9.84	37.52	42.77	62.20	103.24
Tangible Book Value	-17.34	-5.44	-4.17	11.1	28.44	31.45
Tangible Book Value Per Share	-2.36	-0.79	-2.17	8.16	22.11	37.95
Machinery	-	1.07	1.25	1.07	1.1	0.97
Leasehold Improvements	-	0.35	0.34	0.33	0.14	0.15

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error